Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added; Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:47:34.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added IQVIA Pty Ltd as a collaborator in the Collaborators and Investigators section and removed the misspelled entry 'Iqvia Pty Ltd' to correct the collaborator list.
    Difference
    0.1%
    Check dated 2026-04-09T09:16:25.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; this appears to be an administrative update rather than a change to the trial details.
    Difference
    0.1%
    Check dated 2026-03-18T22:28:30.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. No user-visible content changes detected in the screenshots.
    Difference
    0.1%
    Check dated 2026-03-11T18:33:10.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:24:01.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added a government funding notice banner about potential delays and data currency; updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:00:23.000Z thumbnail image

Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.